Genomics

Dataset Information

0

An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease-19 (COVID-19) pandemic, was identified in late 2019 and went on to cause over 3.3 million deaths in 15 months. To date, targeted antiviral interventions against COVID-19 are limited. The spectrum of SARS-CoV-2 infection ranges from asymptomatic to fatal disease. However, the reasons for varying outcomes to SARS-CoV-2 infection are yet to be elucidated. Here we show that an endogenously activated interferon lambda (IFNλ) pathway leads to resistance against SARS-CoV-2 infection. Using a well-differentiated primary nasal epithelial cell (WD-PNEC) model from multiple adult donors, we discovered that susceptibility to SARS-CoV-2 infection, but not respiratory syncytial virus (RSV) infection, varied. One of four donors was resistant to SARS-CoV-2 infection. High baseline IFNλ expression levels and associated interferon stimulated genes correlated with resistance to SARS-CoV-2 infection. Inhibition of the JAK/STAT pathway in WD-PNECs with high endogenous IFNλ secretion resulted in higher SARS-CoV-2 titres. Conversely, prophylactic IFNλ treatment of WD-PNECs susceptible to infection resulted in reduced viral titres. An endogenously activated IFNλ response, possibly due to genetic differences, may be one explanation for the differences in susceptibility to SARS-CoV-2 infection in humans.

ORGANISM(S): Homo sapiens

PROVIDER: GSE199743 | GEO | 2022/04/05

REPOSITORIES: GEO

Similar Datasets

| 2364120 | ecrin-mdr-crc
2022-07-25 | GSE208034 | GEO
2020-06-19 | GSE150392 | GEO
2023-01-31 | GSE208076 | GEO
2023-05-01 | GSE206677 | GEO
2020-11-06 | GSE160435 | GEO
2020-11-06 | GSE155518 | GEO
| E-MTAB-10431 | biostudies-arrayexpress
2023-07-11 | GSE236651 | GEO
2022-08-31 | GSE183850 | GEO